ArticleSage open aging
Sarcopenia Risk, Bone Turnover and Metabolic Health Indices Among Community-Dwelling Older Adults in Ghana: An Observational Study.
Article in Sage open aging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examined the risk of sarcopenia and its association with bone turnover markers, insulin resistance, and skeletal muscle mass among community-dwelling older adults in Ghana. In this cross-sectional study, 140 adults aged ≥60 years were assessed using the SARC-F questionnaire to estimate the risk of sarcopenia. Skeletal muscle mass was estimated using bioelectrical impedance analysis (Omron HBF-514), and metabolic and bone turnover markers were measured in fasting blood samples. The prevalence of sarcopenia risk was 44.3%, with women facing more difficulties climbing stairs. The risk of sarcopenia was more common in older age groups. Sarcopenia risk was associated with higher insulin resistance (τ = .475), C-telopeptide (τ = .540), urine calcium/creatinine ratio (τ = .620), and osteocalcin (τ = .651), but with lower skeletal muscle mass (τ = -.624; all
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.